Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition (Woo, 2024),
Chapter 1-57 Test Bank
,Table of Contents
CHAPTER 1. THE ROLE OF THE NURSE PRACTITIONER ........................................................................... 4
CHAPTER 2. REVIEW OF BASIC PRINCIPLES OF PHARMACOLOGY .......................................................... 5
CHAPTER 3. RATIONAL DRUG SELECTION ............................................................................................. 14
CHAPTER 4. LEGAL AND PROFESSIONAL ISSUES IN PRESCRIBING ........................................................ 17
CHAPTER 5. ADVERSE DRUG REACTIONS .............................................................................................. 20
CHAPTER 6. PHARMACOECONOMICS ................................................................................................... 24
CHAPTER 7. NUTRITION AND NUTRACEUTICALS .................................................................................. 27
CHAPTER 8. HERBAL THERAPY AND NUTRITIONAL SUPPLEMENTS ...................................................... 36
CHAPTER 9. INFORMATICS .................................................................................................................... 39
CHAPTER 10. PHARMACOECONOMICS ................................................................................................. 44
CHAPTER 11. DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM .............................................. 47
CHAPTER 12. DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM .................................................... 57
CHAPTER 13. DRUGS AFFECTING THE CARDIOVASCULAR AND RENAL SYSTEMS................................. 68
CHAPTER 14. DRUGS AFFECTING THE RESPIRATORY SYSTEM .............................................................. 79
CHAPTER 15. DRUGS AFFECTING THE HEMATOLOGICAL SYSTEM ....................................................... 84
CHAPTER 16. DRUGS AFFECTING THE IMMUNE SYSTEM ..................................................................... 90
CHAPTER 17. DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM .................................................... 94
CHAPTER 18. DRUGS AFFECTING THE ENDOCRINE SYSTEM: PANCREATIC HORMONES AND
ANTIDIABETIC DRUGS ........................................................................................................................... 97
CHAPTER 19. DRUGS AFFECTING THE ENDOCRINE SYSTEM: PITUITARY, THYROID, AND ADRENAL
DRUGS ................................................................................................................................................. 104
CHAPTER 20. DRUGS AFFECTING THE REPRODUCTIVE SYSTEM ......................................................... 117
CHAPTER 21. DRUGS AFFECTING THE BONES AND JOINTS ................................................................ 123
CHAPTER 22. DRUGS AFFECTING THE INTEGUMENTARY SYSTEM ..................................................... 129
CHAPTER 23. DRUGS USED IN TREATING BACTERIAL DISEASES ......................................................... 135
CHAPTER 24. DRUGS USED TO TREAT VIRAL, FUNGAL, AND PROTOZOAL INFECTIONS..................... 141
CHAPTER 25. DRUGS USED IN TREATING INFLAMMATORY PROCESSES ............................................ 147
CHAPTER 26. DRUGS USED IN TREATING EYE AND EAR DISORDERS .................................................. 152
CHAPTER 27. ALCOHOL AND DRUG ADDICTION ................................................................................. 155
CHAPTER 28. ANEMIA ......................................................................................................................... 160
CHAPTER 29. ANGINA ......................................................................................................................... 164
CHAPTER 30. ANXIETY AND DEPRESSION ........................................................................................... 169
CHAPTER 31. ATTENTION DEFICIT HYPERACTIVITY DISORDER ........................................................... 173
CHAPTER 32. ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE .................................... 176
CHAPTER 33. CONTRACEPTION........................................................................................................... 180
,CHAPTER 34. DERMATOLOGIC CONDITIONS ...................................................................................... 183
CHAPTER 35. DIABETES MANAGEMENT ............................................................................................. 188
CHAPTER 36. GASTROESOPHAGEAL REFLUX AND PEPTIC ULCER DISEASE ........................................ 198
CHAPTER 37. HEADACHES ................................................................................................................... 201
CHAPTER 38. HEART FAILURE ............................................................................................................. 205
CHAPTER 39. HUMAN IMMUNODEFICIENCY VIRUS DISEASE AND ACQUIRED IMMUNODEFICIENCY
SYNDROME ......................................................................................................................................... 211
CHAPTER 40. HORMONE REPLACEMENT THERAPY ............................................................................ 214
CHAPTER 41. HYPERLIPIDEMIA ........................................................................................................... 219
CHAPTER 42. HYPERTENSION ............................................................................................................. 223
CHAPTER 43. HYPERTHYROIDISM AND HYPOTHYROIDISM ................................................................ 228
CHAPTER 44. PAIN MANAGEMENT: ACUTE AND CHRONIC PAIN ....................................................... 232
CHAPTER 45. PNEUMONIA ................................................................................................................. 236
CHAPTER 46. SMOKING CESSATION ................................................................................................... 239
CHAPTER 47. SEXUALLY TRANSMITTED INFECTIONS AND VAGINITIS ................................................ 242
CHAPTER 48. TUBERCULOSIS .............................................................................................................. 246
CHAPTER 49. UPPER RESPIRATORY INFECTION, PHARYNGITIS, SINUSITIS, OTITIS MEDIA, AND OTITIS
EXTERNA ............................................................................................................................................. 249
CHAPTER 50. URINARY TRACT INFECTIONS ........................................................................................ 252
CHAPTER 51: WOMEN AS PATIENTS ................................................................................................... 255
CHAPTER 52. MEN AS PATIENTS ......................................................................................................... 260
CHAPTER 53. PEDIATRIC PATIENTS ..................................................................................................... 262
CHAPTER 54. TRANSGENDERED CLIENTS AS PATIENTS ...................................................................... 265
CHAPTER 55. GERIATRIC PATIENTS ..................................................................................................... 269
CHAPTER 56. TRANSGENDERED CLIENTS AS PATIENTS ...................................................................... 277
CHAPTER 57: GERIATRIC PATIENTS ..................................................................................................... 280
, PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE PRESCRIBERS 6TH EDITION WOO
ROBINSON TEST BANK
PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE PRESCRIBERS 6TH EDITION WOO
ROBINSON TEST BANK
CHAPTER 1. THE ROLE OF THE NURSE PRACTITIONER
MULTIPLE CHOICE
IDENTIFY THE CHOICE THAT BEST COMPLETES THE STATEMENT OR ANSWERS THE QUESTION.
1. NURSE PRACTITIONER PRESCRIPTIVE AUTHORITY IS REGULATED BY:
1. THE NATIONAL COUNCIL OF STATE BOARDS OF NURSING
2. THE U.S. DRUG ENFORCEMENT ADMINISTRATION
3. THE STATE BOARD OF NURSING FOR EACH STATE
4. THE STATE BOARD OF PHARMACY
2. THE BENEFITS TO THE PATIENT OF HAVING AN ADVANCED PRACTICE REGISTERED
NURSE (APRN) PRESCRIBER INCLUDE:
1. NURSES KNOW MORE ABOUT PHARMACOLOGY THAN OTHER PRESCRIBERS BECAUSE THEY
TAKE IT BOTH IN THEIR BASIC NURSING PROGRAM AND IN THEIR APRN PROGRAM.
2. NURSES CARE FOR THE PATIENT FROM A HOLISTIC APPROACH AND INCLUDE THE PATIENT
IN DECISION MAKING REGARDING THEIR CARE.
3. APRNS ARE LESS LIKELY TO PRESCRIBE NARCOTICS AND OTHER CONTROLLED SUBSTANCES.
4. APRNS ARE ABLE TO PRESCRIBE INDEPENDENTLY IN ALL STATES, WHEREAS A PHYSICIAN’S
ASSISTANT NEEDS TO HAVE A PHYSICIAN SUPERVISING THEIR PRACTICE.
3. CLINICAL JUDGMENT IN PRESCRIBING INCLUDES:
1. FACTORING IN THE COST TO THE PATIENT OF THE MEDICATION PRESCRIBED
2. ALWAYS PRESCRIBING THE NEWEST MEDICATION AVAILABLE FOR THE DISEASE PROCESS
3. HANDING OUT DRUG SAMPLES TO POOR PATIENTS
4. PRESCRIBING ALL GENERIC MEDICATIONS TO CUT COSTS
4. CRITERIA FOR CHOOSING AN EFFECTIVE DRUG FOR A DISORDER INCLUDE:
1. ASKING THE PATIENT WHAT DRUG THEY THINK WOULD WORK BEST FOR THEM
2. CONSULTING NATIONALLY RECOGNIZED GUIDELINES FOR DISEASE MANAGEMENT
3. PRESCRIBING MEDICATIONS THAT ARE AVAILABLE AS SAMPLES BEFORE WRITING A
PRESCRIPTION
Chapter 1-57 Test Bank
,Table of Contents
CHAPTER 1. THE ROLE OF THE NURSE PRACTITIONER ........................................................................... 4
CHAPTER 2. REVIEW OF BASIC PRINCIPLES OF PHARMACOLOGY .......................................................... 5
CHAPTER 3. RATIONAL DRUG SELECTION ............................................................................................. 14
CHAPTER 4. LEGAL AND PROFESSIONAL ISSUES IN PRESCRIBING ........................................................ 17
CHAPTER 5. ADVERSE DRUG REACTIONS .............................................................................................. 20
CHAPTER 6. PHARMACOECONOMICS ................................................................................................... 24
CHAPTER 7. NUTRITION AND NUTRACEUTICALS .................................................................................. 27
CHAPTER 8. HERBAL THERAPY AND NUTRITIONAL SUPPLEMENTS ...................................................... 36
CHAPTER 9. INFORMATICS .................................................................................................................... 39
CHAPTER 10. PHARMACOECONOMICS ................................................................................................. 44
CHAPTER 11. DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM .............................................. 47
CHAPTER 12. DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM .................................................... 57
CHAPTER 13. DRUGS AFFECTING THE CARDIOVASCULAR AND RENAL SYSTEMS................................. 68
CHAPTER 14. DRUGS AFFECTING THE RESPIRATORY SYSTEM .............................................................. 79
CHAPTER 15. DRUGS AFFECTING THE HEMATOLOGICAL SYSTEM ....................................................... 84
CHAPTER 16. DRUGS AFFECTING THE IMMUNE SYSTEM ..................................................................... 90
CHAPTER 17. DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM .................................................... 94
CHAPTER 18. DRUGS AFFECTING THE ENDOCRINE SYSTEM: PANCREATIC HORMONES AND
ANTIDIABETIC DRUGS ........................................................................................................................... 97
CHAPTER 19. DRUGS AFFECTING THE ENDOCRINE SYSTEM: PITUITARY, THYROID, AND ADRENAL
DRUGS ................................................................................................................................................. 104
CHAPTER 20. DRUGS AFFECTING THE REPRODUCTIVE SYSTEM ......................................................... 117
CHAPTER 21. DRUGS AFFECTING THE BONES AND JOINTS ................................................................ 123
CHAPTER 22. DRUGS AFFECTING THE INTEGUMENTARY SYSTEM ..................................................... 129
CHAPTER 23. DRUGS USED IN TREATING BACTERIAL DISEASES ......................................................... 135
CHAPTER 24. DRUGS USED TO TREAT VIRAL, FUNGAL, AND PROTOZOAL INFECTIONS..................... 141
CHAPTER 25. DRUGS USED IN TREATING INFLAMMATORY PROCESSES ............................................ 147
CHAPTER 26. DRUGS USED IN TREATING EYE AND EAR DISORDERS .................................................. 152
CHAPTER 27. ALCOHOL AND DRUG ADDICTION ................................................................................. 155
CHAPTER 28. ANEMIA ......................................................................................................................... 160
CHAPTER 29. ANGINA ......................................................................................................................... 164
CHAPTER 30. ANXIETY AND DEPRESSION ........................................................................................... 169
CHAPTER 31. ATTENTION DEFICIT HYPERACTIVITY DISORDER ........................................................... 173
CHAPTER 32. ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE .................................... 176
CHAPTER 33. CONTRACEPTION........................................................................................................... 180
,CHAPTER 34. DERMATOLOGIC CONDITIONS ...................................................................................... 183
CHAPTER 35. DIABETES MANAGEMENT ............................................................................................. 188
CHAPTER 36. GASTROESOPHAGEAL REFLUX AND PEPTIC ULCER DISEASE ........................................ 198
CHAPTER 37. HEADACHES ................................................................................................................... 201
CHAPTER 38. HEART FAILURE ............................................................................................................. 205
CHAPTER 39. HUMAN IMMUNODEFICIENCY VIRUS DISEASE AND ACQUIRED IMMUNODEFICIENCY
SYNDROME ......................................................................................................................................... 211
CHAPTER 40. HORMONE REPLACEMENT THERAPY ............................................................................ 214
CHAPTER 41. HYPERLIPIDEMIA ........................................................................................................... 219
CHAPTER 42. HYPERTENSION ............................................................................................................. 223
CHAPTER 43. HYPERTHYROIDISM AND HYPOTHYROIDISM ................................................................ 228
CHAPTER 44. PAIN MANAGEMENT: ACUTE AND CHRONIC PAIN ....................................................... 232
CHAPTER 45. PNEUMONIA ................................................................................................................. 236
CHAPTER 46. SMOKING CESSATION ................................................................................................... 239
CHAPTER 47. SEXUALLY TRANSMITTED INFECTIONS AND VAGINITIS ................................................ 242
CHAPTER 48. TUBERCULOSIS .............................................................................................................. 246
CHAPTER 49. UPPER RESPIRATORY INFECTION, PHARYNGITIS, SINUSITIS, OTITIS MEDIA, AND OTITIS
EXTERNA ............................................................................................................................................. 249
CHAPTER 50. URINARY TRACT INFECTIONS ........................................................................................ 252
CHAPTER 51: WOMEN AS PATIENTS ................................................................................................... 255
CHAPTER 52. MEN AS PATIENTS ......................................................................................................... 260
CHAPTER 53. PEDIATRIC PATIENTS ..................................................................................................... 262
CHAPTER 54. TRANSGENDERED CLIENTS AS PATIENTS ...................................................................... 265
CHAPTER 55. GERIATRIC PATIENTS ..................................................................................................... 269
CHAPTER 56. TRANSGENDERED CLIENTS AS PATIENTS ...................................................................... 277
CHAPTER 57: GERIATRIC PATIENTS ..................................................................................................... 280
, PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE PRESCRIBERS 6TH EDITION WOO
ROBINSON TEST BANK
PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSE PRESCRIBERS 6TH EDITION WOO
ROBINSON TEST BANK
CHAPTER 1. THE ROLE OF THE NURSE PRACTITIONER
MULTIPLE CHOICE
IDENTIFY THE CHOICE THAT BEST COMPLETES THE STATEMENT OR ANSWERS THE QUESTION.
1. NURSE PRACTITIONER PRESCRIPTIVE AUTHORITY IS REGULATED BY:
1. THE NATIONAL COUNCIL OF STATE BOARDS OF NURSING
2. THE U.S. DRUG ENFORCEMENT ADMINISTRATION
3. THE STATE BOARD OF NURSING FOR EACH STATE
4. THE STATE BOARD OF PHARMACY
2. THE BENEFITS TO THE PATIENT OF HAVING AN ADVANCED PRACTICE REGISTERED
NURSE (APRN) PRESCRIBER INCLUDE:
1. NURSES KNOW MORE ABOUT PHARMACOLOGY THAN OTHER PRESCRIBERS BECAUSE THEY
TAKE IT BOTH IN THEIR BASIC NURSING PROGRAM AND IN THEIR APRN PROGRAM.
2. NURSES CARE FOR THE PATIENT FROM A HOLISTIC APPROACH AND INCLUDE THE PATIENT
IN DECISION MAKING REGARDING THEIR CARE.
3. APRNS ARE LESS LIKELY TO PRESCRIBE NARCOTICS AND OTHER CONTROLLED SUBSTANCES.
4. APRNS ARE ABLE TO PRESCRIBE INDEPENDENTLY IN ALL STATES, WHEREAS A PHYSICIAN’S
ASSISTANT NEEDS TO HAVE A PHYSICIAN SUPERVISING THEIR PRACTICE.
3. CLINICAL JUDGMENT IN PRESCRIBING INCLUDES:
1. FACTORING IN THE COST TO THE PATIENT OF THE MEDICATION PRESCRIBED
2. ALWAYS PRESCRIBING THE NEWEST MEDICATION AVAILABLE FOR THE DISEASE PROCESS
3. HANDING OUT DRUG SAMPLES TO POOR PATIENTS
4. PRESCRIBING ALL GENERIC MEDICATIONS TO CUT COSTS
4. CRITERIA FOR CHOOSING AN EFFECTIVE DRUG FOR A DISORDER INCLUDE:
1. ASKING THE PATIENT WHAT DRUG THEY THINK WOULD WORK BEST FOR THEM
2. CONSULTING NATIONALLY RECOGNIZED GUIDELINES FOR DISEASE MANAGEMENT
3. PRESCRIBING MEDICATIONS THAT ARE AVAILABLE AS SAMPLES BEFORE WRITING A
PRESCRIPTION
